Ned 19
CAS No. 874374-25-1
Ned 19 ( —— )
产品货号. M33037 CAS No. 874374-25-1
Ned 19 是一种选择性膜透性非竞争性 NAADP 拮抗剂,抑制 NAADP 介导的 Ca2+ 信号传导,IC50 为 65 nM。 Ned 19 强烈抑制小鼠的肿瘤生长和血管形成以及肺转移。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥790 | 有现货 |
|
| 5MG | ¥1311 | 有现货 |
|
| 10MG | ¥2043 | 有现货 |
|
| 25MG | ¥3302 | 有现货 |
|
| 50MG | ¥4631 | 有现货 |
|
| 100MG | ¥6255 | 有现货 |
|
| 500MG | ¥12510 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1511 | 有现货 |
|
生物学信息
-
产品名称Ned 19
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ned 19 是一种选择性膜透性非竞争性 NAADP 拮抗剂,抑制 NAADP 介导的 Ca2+ 信号传导,IC50 为 65 nM。 Ned 19 强烈抑制小鼠的肿瘤生长和血管形成以及肺转移。
-
产品描述Ned 19 is a selective membrane-permeant non competitive NAADP antagonist and inhibits NAADP-mediated Ca2+ signaling, with anIC50 of 65 nM. Ned 19 strongly inhibits tumor growth and vascularization as well as lung metastases in mice.
-
体外实验Ned 19 (25-100 μM; 24-72?hours) reduces cell proliferation.Ned 19 (25-100 μM; 24-72?hours) reduces markedly the cell number.Ned 19 (25-100 μM; 24-72?hours) reduces the S phase percentage and increases of the G0/G1 phase percentage evaluated by cell cycle analysis. Ned 19 (25-100 μM; 24-72?hours) induces cell apoptosis a time-dependent manner. Ned 19 (25-100 μM; 24-72?hours) reduces expression of N-cadherin and increases expression of E-cadherin, affecting the cell migratory behavior. Cell Proliferation Assay Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced cell proliferation.Cell Viability Assay Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced markedly the cell number. Cell Cycle Analysis Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced the S phase percentage and increased of the G0/G1 phase percentage.Apoptosis AnalysisCell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Induced cell apoptosis a time-dependent manner.Western Blot Analysis Cell Line:B16 cells Concentration:25, 50, 100 μM Incubation Time:24, 48, 72?hours Result:Reduced expression of N-cadherin and increased expression of E-cadherin.
-
体内实验Ned 19 (i.p.; 5?mg/Kg/every second day; 4 week) impaires severely tumor growth. Animal Model:Adult male C57BL/6 mice Dosage:5?mg/Kg Administration:I.p.; every second day; 4 week Result:Impaired severely tumor growth.
-
同义词——
-
通路GPCR/G Protein
-
靶点Calcium Channel
-
受体Calcium Channel
-
研究领域——
-
适应症——
化学信息
-
CAS Number874374-25-1
-
分子量514.59
-
分子式C30H31FN4O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 125 mg/mL (242.91 mM; 超声助溶 )
-
SMILESC(O)(=O)C1CC2=C(C(N1)C3=CC(CN4CCN(CC4)C5=C(F)C=CC=C5)=C(OC)C=C3)NC=6C2=CC=CC6
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Rosen D, et al. Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonistNed-19 indicate two binding sites on the NAADP receptor. J Biol Chem. 2009 Dec 11;284(50):34930-4.?
产品手册
关联产品
-
Calcium channel-modu...
Calcium channel-modulator-1是钙离子通道 (calcium channel) 调节剂,阻塞主动脉收缩的 IC50 值为0.8 μM。
-
Lanthanum(III) chlor...
氯化镧(III) 是一种无机化合物,在生化研究中用于阻断二价阳离子通道,特别是钙通道的活性。
-
Mirogabalin
Mirogabalin (DS-5565) 是电压门控钙通道 α2δ 亚基的新型有效选择性配体,对人 α2δ-1、人 α2δ-2、大鼠 α2δ-1 和大鼠 α2δ-1 的 Kd 为 13.5/22.7/27.0/47.6 nM分别为大鼠α2δ-2亚基。
021-51111890
购物车()
sales@molnova.cn

